Factors involved in treatment preference in patients with renal cancer: pazopanib versus sunitinib
Catherine C Mitchell, Omi A Parikh Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK Abstract: The last decade has seen a surge in the treatment options for metastatic renal cell carcinoma and life expectancies are now approaching 3 years from diagnosis. There is some sug...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/factors-involved-in-treatment-preference-in-patients-with-renal-cancer-a16535 |